Bel20 boekt kleine winst -16 oktober 2023 om 1118 uur - Marketscreener NL
| BTLS Stock | 3.62 0.08 2.26% |
Slightly above 55% of Biotalys' retail investors are presently thinking to get in. The analysis of current outlook of investing in Biotalys NV suggests that some traders are interested regarding Biotalys' prospects. Biotalys' investing sentiment overview a quick insight into current market opportunities from investing in Biotalys NV. Many technical investors use Biotalys NV stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Biotalys stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Biotalys daily returns and investor perception about the current price of Biotalys NV as well as its diversification or hedging effects on your existing portfolios.
Biotalys |
Bel20 boekt kleine winst -16 oktober 2023 om 1118 uur Marketscreener NL
Read at news.google.com
 |
Biotalys Fundamental Analysis
We analyze Biotalys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotalys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotalys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Biotalys is rated below average in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Biotalys NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotalys stock to make a market-neutral strategy. Peer analysis of Biotalys could also be used in its relative valuation, which is a method of valuing Biotalys by comparing valuation metrics with similar companies.
Peers
Biotalys Related Equities
| SEQUA | Sequana Medical | 17.88 | ||||
| MELE | Melexis NV | 6.07 | ||||
| BTLS | Biotalys | 2.26 | ||||
| NEXTA | Nextensa | 1.61 | ||||
| KBCA | KBC Ancora | 1.37 | ||||
| AGS | Ageas SANV | 0.21 | ||||
| TITC | Titan Cement | 0.38 |
Additional Tools for Biotalys Stock Analysis
When running Biotalys' price analysis, check to measure Biotalys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotalys is operating at the current time. Most of Biotalys' value examination focuses on studying past and present price action to predict the probability of Biotalys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotalys' price. Additionally, you may evaluate how the addition of Biotalys to your portfolios can decrease your overall portfolio volatility.